A randomized trial of peginteferon alfa-2b and lamivudine combination treatment versus lamivudine monotherapy in Chinese patients with HBeAg-positive chronic hepatitis B

被引：1
|
作者：
Chan, HLY
Leung, NWY
Hui, AY
Liew, CT
Chim, AML
Chan, FKL
Hung, LCT
Sung, JJY
机构：
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[2] Alice Ho Nethersole Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2004年 / 40卷
关键词：
D O I：
10.1016/S0168-8278(04)90423-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
423
引用
收藏
页码：125 / 126
页数：2
相关论文
共 50 条
  • [21] Lamivudine and Adefovir Combination Therapy in Lamivudine Resistant HBeAg Positive Chronic Hepatitis B Patients
    Lee, H. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A190 - A190
  • [22] Peginterferon alfa-2b as monotherapy or in combination with lamivudine in patients with HeAg-negative chronic hepatitis B: A randomised study
    Papadopoulos, Vasilelos P.
    Chrysagis, Dimitrios N.
    Protopapas, Andreas N.
    Goulis, Ioannis G.
    Dimitriadis, Georgios T.
    Mimidis, Konstantinos P.
    MEDICAL SCIENCE MONITOR, 2009, 15 (02): : CR56 - CR61
  • [23] Lamivudine and adefovir versus adefovir alone for HBeAg-positive chronic hepatitis B.
    Ghany, M
    Lutchman, G
    Kleiner, D
    Borg, B
    Heller, T
    Feld, J
    Loomba, R
    Park, Y
    Liang, TJ
    Hoofnagle, J
    HEPATOLOGY, 2005, 42 (04) : 591A - 592A
  • [24] Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B
    Yurdaydin, C
    Bozkaya, H
    Çetinkaya, H
    Sahin, T
    Karaoguz, D
    Törüner, M
    Erkan, Ö
    Heper, AO
    Erden, E
    Bozdayi, AM
    Uzunalimoglu, Ö
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) : 262 - 268
  • [25] Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B
    Shin, JW
    Park, NH
    Park, JH
    Park, JH
    Jeong, ID
    Bang, SJ
    Joo, KR
    Kim, DH
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (04) : 393 - 397
  • [26] Interferon alone or in combination with lamivudine for HbeAg-positive chronic hepatitis B: a meta-analysis
    Chua, Jeffrey M.
    Payawal, Diana
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A448 - A449
  • [27] Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B
    Papadopoulos, Vasileios
    Protopapas, Andreas
    Tsianos, Epameinondas
    Mimidis, Konstantinos
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (08) : 1021 - 1022
  • [28] Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine
    Flink, Hajo J.
    Hansen, Bettina E.
    Heathcote, E. Jenny
    Feinman, S. Victor
    Simsek, Halis
    Karayalcin, Selim
    Mach, Tomasz
    Leemans, Wim F.
    de Man, Robert A.
    Verhey, Elke
    Schalm, Solko W.
    Janssen, Harry L. A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (11): : 2523 - 2529
  • [29] Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B
    David L. Veenstra
    Sean D. Sullivan
    Lauren Clarke
    Uche H. Iloeje
    Eskinder Tafesse
    Adrian Di Bisceglie
    Kris V. Kowdley
    Robert G. Gish
    PharmacoEconomics, 2007, 25 : 963 - 977
  • [30] Higher efficacy of sequential therapy with interferon-α and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients
    Sarin, SK
    Kumar, M
    Kumar, R
    Kazim, SN
    Guptan, RC
    Sakhuja, P
    Sharma, BC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2463 - 2471
12345